Clinical Study: Cysticlean vs. Placebo Randomized, Double-Blind, 12-Month Trial [cite: 4, 12] 51% Reduction in UTIs [cite: 16, 148] 7 Months Median UTI-Free Survival [cite: 150] Zero Adverse Events Reported [cite: 18, 169] Percentage of women suffering frequent recurrences (≥3 UTIs/year): Cysticlean Group 3.8% [cite: 147, 181] Placebo Group 51.3% [cite: 147, 184] Want to see the science for yourself? Explore the peer-reviewed data behind these results. VIEW FULL CLINICAL STUDY → Gold-standard randomized, double-blinded trial [cite: 4, 15] Long-term efficacy tested on 160 women over 12 months [cite: 15,...
Read more...
